| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 46 | 2019 | 1211 | 6.430 |
Why?
|
| Nanoparticles | 28 | 2018 | 1905 | 3.570 |
Why?
|
| Tissue Engineering | 25 | 2017 | 1880 | 3.270 |
Why?
|
| Liver | 33 | 2019 | 7474 | 2.700 |
Why?
|
| RNA, Small Interfering | 16 | 2019 | 3505 | 2.660 |
Why?
|
| Polyethylene Glycols | 15 | 2018 | 1182 | 2.460 |
Why?
|
| Cell Culture Techniques | 19 | 2018 | 1678 | 2.370 |
Why?
|
| Nanotechnology | 9 | 2015 | 710 | 1.520 |
Why?
|
| Coculture Techniques | 17 | 2018 | 1341 | 1.420 |
Why?
|
| Hydrogels | 8 | 2015 | 724 | 1.400 |
Why?
|
| Peptide Hydrolases | 5 | 2018 | 634 | 1.360 |
Why?
|
| Nanomedicine | 6 | 2015 | 304 | 1.340 |
Why?
|
| Microfluidics | 10 | 2014 | 662 | 1.310 |
Why?
|
| Liver, Artificial | 5 | 2015 | 56 | 1.210 |
Why?
|
| Plasmodium | 6 | 2019 | 250 | 1.200 |
Why?
|
| Malaria | 10 | 2019 | 1239 | 1.180 |
Why?
|
| Plasmodium vivax | 4 | 2018 | 208 | 1.170 |
Why?
|
| Biosensing Techniques | 8 | 2018 | 668 | 1.140 |
Why?
|
| Neoplasms, Experimental | 4 | 2018 | 1276 | 1.120 |
Why?
|
| Cell Communication | 9 | 2014 | 1621 | 1.110 |
Why?
|
| Hepatitis B virus | 4 | 2017 | 513 | 1.040 |
Why?
|
| Microfluidic Analytical Techniques | 8 | 2013 | 828 | 1.020 |
Why?
|
| Nanostructures | 7 | 2014 | 551 | 1.010 |
Why?
|
| Biocompatible Materials | 13 | 2012 | 1736 | 0.970 |
Why?
|
| Mice, Nude | 17 | 2019 | 3689 | 0.960 |
Why?
|
| Silicon | 9 | 2017 | 145 | 0.950 |
Why?
|
| Drug Carriers | 8 | 2010 | 693 | 0.940 |
Why?
|
| Hepacivirus | 5 | 2016 | 1379 | 0.920 |
Why?
|
| Mice | 76 | 2019 | 81183 | 0.890 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2016 | 1736 | 0.890 |
Why?
|
| Culture Techniques | 4 | 2007 | 554 | 0.890 |
Why?
|
| Antimalarials | 7 | 2018 | 905 | 0.880 |
Why?
|
| Life Cycle Stages | 5 | 2018 | 160 | 0.860 |
Why?
|
| Animals | 111 | 2019 | 168757 | 0.860 |
Why?
|
| Peptides | 11 | 2017 | 4409 | 0.850 |
Why?
|
| Rats, Inbred Lew | 15 | 2015 | 1162 | 0.830 |
Why?
|
| High-Throughput Screening Assays | 4 | 2016 | 944 | 0.770 |
Why?
|
| Quantum Dots | 5 | 2010 | 172 | 0.740 |
Why?
|
| Hepatitis C | 6 | 2016 | 1591 | 0.730 |
Why?
|
| Hyperthermia, Induced | 3 | 2015 | 403 | 0.720 |
Why?
|
| Liver Diseases | 3 | 2017 | 1253 | 0.720 |
Why?
|
| RNA Interference | 4 | 2019 | 2889 | 0.710 |
Why?
|
| Extracellular Matrix | 9 | 2016 | 1741 | 0.710 |
Why?
|
| Cells, Cultured | 30 | 2015 | 19229 | 0.700 |
Why?
|
| Drug Discovery | 5 | 2019 | 1058 | 0.690 |
Why?
|
| 3T3 Cells | 9 | 2019 | 1101 | 0.690 |
Why?
|
| Ovarian Neoplasms | 7 | 2016 | 4838 | 0.670 |
Why?
|
| Metal Nanoparticles | 3 | 2014 | 405 | 0.660 |
Why?
|
| Cell Line, Tumor | 30 | 2018 | 16689 | 0.660 |
Why?
|
| Stromal Cells | 4 | 2019 | 1355 | 0.660 |
Why?
|
| Molecular Imaging | 2 | 2016 | 828 | 0.650 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2018 | 44 | 0.640 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2018 | 83 | 0.630 |
Why?
|
| Fibroblasts | 10 | 2018 | 4161 | 0.590 |
Why?
|
| Plasmodium falciparum | 8 | 2019 | 1732 | 0.570 |
Why?
|
| Electrophoresis | 2 | 2007 | 240 | 0.540 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 795 | 0.530 |
Why?
|
| Galectin 3 | 2 | 2014 | 227 | 0.530 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1655 | 0.530 |
Why?
|
| Gene Library | 1 | 2018 | 1074 | 0.530 |
Why?
|
| Virus Replication | 5 | 2017 | 2534 | 0.520 |
Why?
|
| Drug Delivery Systems | 14 | 2016 | 2219 | 0.520 |
Why?
|
| Host-Pathogen Interactions | 4 | 2018 | 1477 | 0.510 |
Why?
|
| Models, Biological | 10 | 2018 | 9583 | 0.510 |
Why?
|
| Oligopeptides | 3 | 2018 | 1189 | 0.510 |
Why?
|
| Magnetite Nanoparticles | 2 | 2016 | 321 | 0.510 |
Why?
|
| Bioreactors | 6 | 2012 | 236 | 0.510 |
Why?
|
| Surface Plasmon Resonance | 2 | 2013 | 274 | 0.510 |
Why?
|
| Sialyltransferases | 1 | 2014 | 75 | 0.500 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9438 | 0.490 |
Why?
|
| Rats | 29 | 2016 | 24260 | 0.490 |
Why?
|
| Transfection | 3 | 2012 | 5892 | 0.470 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 391 | 0.470 |
Why?
|
| Sporozoites | 5 | 2019 | 82 | 0.470 |
Why?
|
| Cell Differentiation | 12 | 2016 | 11483 | 0.460 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 171 | 0.460 |
Why?
|
| Parasitology | 1 | 2013 | 29 | 0.460 |
Why?
|
| Neoplasms | 19 | 2018 | 21683 | 0.450 |
Why?
|
| Gold | 4 | 2014 | 484 | 0.450 |
Why?
|
| Cell Hypoxia | 2 | 2006 | 675 | 0.440 |
Why?
|
| Artificial Organs | 2 | 2014 | 204 | 0.440 |
Why?
|
| Electromagnetic Fields | 5 | 2007 | 298 | 0.440 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 19 | 0.440 |
Why?
|
| Doxorubicin | 6 | 2015 | 2234 | 0.430 |
Why?
|
| Small Molecule Libraries | 3 | 2018 | 720 | 0.430 |
Why?
|
| Microbiological Techniques | 1 | 2013 | 102 | 0.430 |
Why?
|
| Magnetics | 7 | 2009 | 606 | 0.420 |
Why?
|
| Genome, Viral | 1 | 2016 | 667 | 0.420 |
Why?
|
| HeLa Cells | 8 | 2016 | 3128 | 0.410 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2014 | 214 | 0.410 |
Why?
|
| Albumins | 6 | 2017 | 569 | 0.410 |
Why?
|
| Hemorheology | 1 | 2012 | 145 | 0.400 |
Why?
|
| Thrombosis | 4 | 2014 | 2968 | 0.400 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2015 | 692 | 0.400 |
Why?
|
| Nanocapsules | 1 | 2012 | 91 | 0.400 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2008 | 472 | 0.400 |
Why?
|
| Probiotics | 1 | 2015 | 351 | 0.400 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 18029 | 0.390 |
Why?
|
| Silicon Dioxide | 2 | 2011 | 213 | 0.390 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 351 | 0.390 |
Why?
|
| Blood Coagulation | 2 | 2014 | 1127 | 0.390 |
Why?
|
| Humans | 110 | 2019 | 744343 | 0.380 |
Why?
|
| Gene Targeting | 2 | 2015 | 880 | 0.370 |
Why?
|
| Microtechnology | 1 | 2010 | 70 | 0.360 |
Why?
|
| Phototherapy | 1 | 2013 | 377 | 0.360 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1401 | 0.360 |
Why?
|
| Cell Survival | 13 | 2015 | 5882 | 0.360 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2013 | 627 | 0.350 |
Why?
|
| DNA, Single-Stranded | 1 | 2011 | 354 | 0.350 |
Why?
|
| Nanotubes | 2 | 2010 | 77 | 0.350 |
Why?
|
| Dendrimers | 1 | 2009 | 68 | 0.340 |
Why?
|
| Hot Temperature | 1 | 2015 | 1354 | 0.340 |
Why?
|
| Cell Adhesion | 10 | 2016 | 3144 | 0.330 |
Why?
|
| Colorectal Neoplasms | 4 | 2016 | 6773 | 0.330 |
Why?
|
| Porosity | 7 | 2017 | 362 | 0.330 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 733 | 0.330 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1312 | 0.320 |
Why?
|
| DNA, Viral | 1 | 2015 | 2225 | 0.320 |
Why?
|
| Oncogenes | 3 | 2018 | 1265 | 0.320 |
Why?
|
| Anemia, Sickle Cell | 3 | 2012 | 1018 | 0.320 |
Why?
|
| Host-Parasite Interactions | 4 | 2019 | 295 | 0.320 |
Why?
|
| Materials Testing | 7 | 2009 | 867 | 0.320 |
Why?
|
| Flow Injection Analysis | 1 | 2007 | 22 | 0.310 |
Why?
|
| Delayed-Action Preparations | 1 | 2011 | 968 | 0.310 |
Why?
|
| Micromanipulation | 2 | 2004 | 53 | 0.310 |
Why?
|
| Microarray Analysis | 2 | 2016 | 767 | 0.310 |
Why?
|
| Surface Properties | 8 | 2009 | 1184 | 0.310 |
Why?
|
| Bacteria | 1 | 2018 | 2114 | 0.310 |
Why?
|
| Equipment Design | 10 | 2013 | 3582 | 0.300 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 319 | 0.300 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 156 | 0.300 |
Why?
|
| Drug Design | 2 | 2014 | 1076 | 0.290 |
Why?
|
| Homeostasis | 2 | 2015 | 3340 | 0.290 |
Why?
|
| Cell Line | 10 | 2018 | 15997 | 0.290 |
Why?
|
| Cell Biology | 1 | 2007 | 92 | 0.280 |
Why?
|
| Cattle | 6 | 2014 | 3922 | 0.280 |
Why?
|
| Cadherins | 2 | 2008 | 907 | 0.280 |
Why?
|
| Polymers | 4 | 2011 | 1621 | 0.280 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5256 | 0.280 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10481 | 0.280 |
Why?
|
| Fluorescent Dyes | 4 | 2014 | 1917 | 0.270 |
Why?
|
| Peptides, Cyclic | 1 | 2008 | 400 | 0.270 |
Why?
|
| Neoplasm Transplantation | 6 | 2018 | 2085 | 0.270 |
Why?
|
| Electronics | 1 | 2007 | 322 | 0.270 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2005 | 849 | 0.270 |
Why?
|
| Oxygen | 8 | 2015 | 4189 | 0.270 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2016 | 419 | 0.270 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 4456 | 0.260 |
Why?
|
| Methylcholanthrene | 1 | 2005 | 29 | 0.260 |
Why?
|
| Cytological Techniques | 2 | 2010 | 219 | 0.260 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3586 | 0.260 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1177 | 0.260 |
Why?
|
| Malaria, Vivax | 2 | 2018 | 173 | 0.250 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 91 | 0.250 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 1738 | 0.250 |
Why?
|
| Endothelial Cells | 4 | 2015 | 3479 | 0.250 |
Why?
|
| Ferric Compounds | 6 | 2016 | 374 | 0.250 |
Why?
|
| Biological Assay | 1 | 2007 | 652 | 0.240 |
Why?
|
| Toxicity Tests | 1 | 2004 | 121 | 0.240 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 119 | 0.240 |
Why?
|
| Malaria, Falciparum | 3 | 2019 | 1077 | 0.240 |
Why?
|
| Receptors, Cell Surface | 2 | 2017 | 2866 | 0.240 |
Why?
|
| Biopolymers | 1 | 2004 | 189 | 0.230 |
Why?
|
| Tissue Distribution | 3 | 2016 | 2327 | 0.230 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 613 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.230 |
Why?
|
| Microscopy, Fluorescence | 5 | 2016 | 2699 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7181 | 0.230 |
Why?
|
| Tissue Scaffolds | 3 | 2017 | 956 | 0.220 |
Why?
|
| Fibronectins | 3 | 2013 | 726 | 0.220 |
Why?
|
| Enzyme Inhibitors | 4 | 2015 | 3798 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3557 | 0.210 |
Why?
|
| Models, Chemical | 1 | 2004 | 626 | 0.210 |
Why?
|
| Equipment Failure Analysis | 3 | 2013 | 868 | 0.210 |
Why?
|
| Poloxamer | 1 | 2002 | 57 | 0.210 |
Why?
|
| Tissue Array Analysis | 2 | 2015 | 553 | 0.210 |
Why?
|
| Liver Transplantation | 2 | 2011 | 2119 | 0.210 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 1224 | 0.210 |
Why?
|
| Particle Size | 6 | 2009 | 1642 | 0.210 |
Why?
|
| Hepatitis B | 3 | 2017 | 695 | 0.200 |
Why?
|
| Polyglycolic Acid | 1 | 2003 | 407 | 0.200 |
Why?
|
| Substrate Specificity | 3 | 2018 | 1801 | 0.200 |
Why?
|
| Phenotype | 7 | 2018 | 16365 | 0.200 |
Why?
|
| Bioartificial Organs | 1 | 2001 | 49 | 0.200 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3086 | 0.190 |
Why?
|
| Laminin | 3 | 2016 | 419 | 0.190 |
Why?
|
| Collagen | 6 | 2015 | 2689 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 1219 | 0.180 |
Why?
|
| Perfusion | 2 | 2016 | 1360 | 0.180 |
Why?
|
| Fluorescence | 4 | 2011 | 751 | 0.180 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3589 | 0.170 |
Why?
|
| Insect Vectors | 2 | 2019 | 134 | 0.170 |
Why?
|
| Ecdysterone | 1 | 2019 | 14 | 0.170 |
Why?
|
| Kinetics | 3 | 2018 | 6473 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2014 | 4599 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3647 | 0.170 |
Why?
|
| Gene Silencing | 3 | 2017 | 1538 | 0.170 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 6364 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 13102 | 0.160 |
Why?
|
| ROC Curve | 2 | 2018 | 3527 | 0.160 |
Why?
|
| Female | 36 | 2019 | 380194 | 0.160 |
Why?
|
| Acids | 1 | 2019 | 127 | 0.160 |
Why?
|
| Biotin | 2 | 2011 | 254 | 0.160 |
Why?
|
| Crystallization | 4 | 2009 | 524 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2003 | 1133 | 0.150 |
Why?
|
| Anopheles | 2 | 2019 | 197 | 0.150 |
Why?
|
| Cell Movement | 2 | 2013 | 5217 | 0.150 |
Why?
|
| DNA | 3 | 2009 | 7301 | 0.150 |
Why?
|
| Hep G2 Cells | 3 | 2017 | 393 | 0.150 |
Why?
|
| Plasmodium berghei | 2 | 2016 | 168 | 0.150 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 387 | 0.150 |
Why?
|
| Stem Cells | 2 | 2007 | 3567 | 0.140 |
Why?
|
| Neoplasm Metastasis | 5 | 2019 | 4851 | 0.140 |
Why?
|
| Malaria Vaccines | 1 | 2018 | 158 | 0.140 |
Why?
|
| Calcium Compounds | 1 | 2016 | 34 | 0.140 |
Why?
|
| Photolysis | 1 | 2016 | 92 | 0.140 |
Why?
|
| Silicates | 1 | 2016 | 42 | 0.140 |
Why?
|
| Biotechnology | 2 | 2016 | 281 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 288 | 0.140 |
Why?
|
| Bacteriolysis | 1 | 2016 | 51 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 712 | 0.140 |
Why?
|
| Transferrin | 1 | 2017 | 295 | 0.140 |
Why?
|
| Biomedical Research | 3 | 2017 | 3309 | 0.140 |
Why?
|
| Acetaminophen | 2 | 2014 | 545 | 0.140 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1547 | 0.140 |
Why?
|
| Salmonella | 1 | 2016 | 129 | 0.140 |
Why?
|
| Health Planning | 1 | 2017 | 238 | 0.140 |
Why?
|
| Neglected Diseases | 1 | 2016 | 64 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 658 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2015 | 84 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11124 | 0.130 |
Why?
|
| Parasites | 1 | 2018 | 163 | 0.130 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2006 | 192 | 0.130 |
Why?
|
| Vestibule, Labyrinth | 1 | 2017 | 235 | 0.130 |
Why?
|
| Miniaturization | 2 | 2007 | 164 | 0.130 |
Why?
|
| Azetidines | 1 | 2016 | 142 | 0.130 |
Why?
|
| Endoderm | 1 | 2016 | 154 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2019 | 23403 | 0.130 |
Why?
|
| DNA, Circular | 1 | 2015 | 97 | 0.130 |
Why?
|
| Ligands | 3 | 2013 | 3282 | 0.130 |
Why?
|
| Liposomes | 2 | 2016 | 759 | 0.130 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9734 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2017 | 477 | 0.130 |
Why?
|
| Bacteriophage M13 | 1 | 2014 | 39 | 0.130 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2016 | 1375 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 4042 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2016 | 1375 | 0.120 |
Why?
|
| Erythrocytes | 3 | 2018 | 2455 | 0.120 |
Why?
|
| Cells, Immobilized | 1 | 2014 | 36 | 0.120 |
Why?
|
| Body Patterning | 2 | 2016 | 626 | 0.120 |
Why?
|
| Blood Viscosity | 2 | 2012 | 124 | 0.120 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2016 | 241 | 0.120 |
Why?
|
| Health Priorities | 1 | 2017 | 380 | 0.120 |
Why?
|
| Time Factors | 9 | 2015 | 40075 | 0.120 |
Why?
|
| Forecasting | 3 | 2017 | 2951 | 0.120 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 573 | 0.120 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2015 | 167 | 0.120 |
Why?
|
| Nanotubes, Carbon | 1 | 2014 | 73 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8428 | 0.120 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1878 | 0.120 |
Why?
|
| Partial Pressure | 1 | 2013 | 254 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 640 | 0.120 |
Why?
|
| Gene Expression | 4 | 2019 | 7799 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1117 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 99 | 0.110 |
Why?
|
| Administration, Oral | 3 | 2016 | 3913 | 0.110 |
Why?
|
| Base Sequence | 3 | 2016 | 12797 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2017 | 826 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 411 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2015 | 2716 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 442 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 611 | 0.110 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4253 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 6386 | 0.110 |
Why?
|
| Printing | 1 | 2012 | 46 | 0.110 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 60 | 0.110 |
Why?
|
| Organoids | 1 | 2018 | 701 | 0.110 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 1005 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2557 | 0.100 |
Why?
|
| Infrared Rays | 1 | 2013 | 249 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2505 | 0.100 |
Why?
|
| Cell Compartmentation | 1 | 2013 | 402 | 0.100 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 827 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2017 | 547 | 0.100 |
Why?
|
| Thrombin | 1 | 2014 | 598 | 0.100 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 135 | 0.100 |
Why?
|
| Antisickling Agents | 1 | 2012 | 80 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 12072 | 0.100 |
Why?
|
| Immunoassay | 2 | 2014 | 752 | 0.100 |
Why?
|
| Mitosis | 2 | 2014 | 1208 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 677 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 428 | 0.100 |
Why?
|
| Oxygen Consumption | 3 | 2004 | 1869 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 314 | 0.100 |
Why?
|
| Thromboplastin | 1 | 2013 | 291 | 0.100 |
Why?
|
| Estrogens | 1 | 2019 | 1566 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2016 | 670 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2006 | 1099 | 0.100 |
Why?
|
| Streptavidin | 1 | 2011 | 81 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 2187 | 0.100 |
Why?
|
| Glycosylation | 1 | 2014 | 1126 | 0.100 |
Why?
|
| Light | 2 | 2016 | 1374 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 365 | 0.100 |
Why?
|
| Molecular Structure | 2 | 2013 | 1899 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1222 | 0.100 |
Why?
|
| Estradiol | 1 | 2019 | 2020 | 0.100 |
Why?
|
| Genes, Essential | 1 | 2012 | 183 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.100 |
Why?
|
| Membranes, Artificial | 2 | 2003 | 378 | 0.100 |
Why?
|
| Cytosol | 2 | 2016 | 901 | 0.100 |
Why?
|
| Coumarins | 1 | 2011 | 119 | 0.100 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 2376 | 0.100 |
Why?
|
| Peptide Library | 1 | 2012 | 349 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1692 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2012 | 5179 | 0.100 |
Why?
|
| SOXF Transcription Factors | 1 | 2010 | 29 | 0.100 |
Why?
|
| Luciferases, Renilla | 1 | 2010 | 22 | 0.100 |
Why?
|
| Micelles | 2 | 2010 | 203 | 0.090 |
Why?
|
| HMGB Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2088 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 2012 | 1423 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2187 | 0.090 |
Why?
|
| Comet Assay | 1 | 2010 | 71 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 5172 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 20822 | 0.090 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 179 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 1017 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13815 | 0.090 |
Why?
|
| Plasmids | 1 | 2015 | 2307 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2018 | 1634 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3920 | 0.090 |
Why?
|
| Triazoles | 1 | 2015 | 911 | 0.090 |
Why?
|
| Solutions | 2 | 2014 | 426 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1351 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2014 | 1460 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 1005 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 428 | 0.080 |
Why?
|
| Galectins | 1 | 2012 | 268 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2012 | 936 | 0.080 |
Why?
|
| Contrast Media | 2 | 2014 | 5300 | 0.080 |
Why?
|
| bcl-X Protein | 1 | 2010 | 411 | 0.080 |
Why?
|
| Doxycycline | 1 | 2010 | 326 | 0.080 |
Why?
|
| Cell Separation | 2 | 2005 | 1751 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 440 | 0.080 |
Why?
|
| Antiviral Agents | 3 | 2016 | 2987 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2010 | 2921 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 21827 | 0.080 |
Why?
|
| Azides | 1 | 2008 | 116 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 1107 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2012 | 695 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2886 | 0.080 |
Why?
|
| Electrolytes | 1 | 2008 | 282 | 0.080 |
Why?
|
| Swiss 3T3 Cells | 1 | 2007 | 5 | 0.080 |
Why?
|
| Equipment Reuse | 1 | 2007 | 41 | 0.080 |
Why?
|
| Temperature | 2 | 2011 | 2206 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2010 | 5974 | 0.080 |
Why?
|
| Alkynes | 1 | 2008 | 306 | 0.080 |
Why?
|
| Avidin | 1 | 2007 | 44 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2016 | 2902 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3129 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 1376 | 0.070 |
Why?
|
| Oxides | 1 | 2009 | 405 | 0.070 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2007 | 115 | 0.070 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 1863 | 0.070 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2007 | 58 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6365 | 0.070 |
Why?
|
| Heparin | 1 | 2014 | 1637 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2017 | 1886 | 0.070 |
Why?
|
| Titanium | 1 | 2009 | 494 | 0.070 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 298 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14722 | 0.070 |
Why?
|
| Amines | 1 | 2008 | 276 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6314 | 0.070 |
Why?
|
| Spiral Ganglion | 1 | 2007 | 169 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 816 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2214 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2012 | 1125 | 0.070 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 996 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1549 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10943 | 0.070 |
Why?
|
| Embryonic Stem Cells | 2 | 2010 | 1294 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2009 | 582 | 0.070 |
Why?
|
| Biophysical Phenomena | 1 | 2007 | 327 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4420 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2010 | 501 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1387 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2183 | 0.070 |
Why?
|
| Biophysics | 1 | 2007 | 383 | 0.070 |
Why?
|
| Photons | 2 | 2006 | 588 | 0.070 |
Why?
|
| Paracrine Communication | 1 | 2007 | 277 | 0.070 |
Why?
|
| Neurites | 1 | 2007 | 388 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 689 | 0.070 |
Why?
|
| CHO Cells | 1 | 2008 | 1406 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 411 | 0.070 |
Why?
|
| Biomimetics | 1 | 2007 | 172 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2203 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2004 | 21 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2012 | 1301 | 0.060 |
Why?
|
| Cell Physiological Phenomena | 1 | 2006 | 154 | 0.060 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 38 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 2007 | 0.060 |
Why?
|
| Medicine | 1 | 2013 | 946 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 12208 | 0.060 |
Why?
|
| Endocytosis | 1 | 2009 | 985 | 0.060 |
Why?
|
| Decorin | 1 | 2004 | 40 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1637 | 0.060 |
Why?
|
| Motion | 2 | 2009 | 798 | 0.060 |
Why?
|
| Rheology | 2 | 2003 | 345 | 0.060 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2005 | 129 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2006 | 3508 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2009 | 2008 | 0.060 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2004 | 115 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2472 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.060 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2004 | 115 | 0.060 |
Why?
|
| Safety | 2 | 2016 | 1186 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2016 | 2025 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1900 | 0.060 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 1149 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2016 | 6196 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2013 | 3748 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 721 | 0.060 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2003 | 14 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 257 | 0.060 |
Why?
|
| Glass | 2 | 2012 | 114 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2007 | 793 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2015 | 2942 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2005 | 440 | 0.060 |
Why?
|
| Environment | 1 | 2009 | 1124 | 0.060 |
Why?
|
| Silicon Compounds | 1 | 2002 | 15 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2018 | 2969 | 0.060 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2002 | 56 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2421 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 8949 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 209 | 0.050 |
Why?
|
| Polystyrenes | 3 | 2008 | 112 | 0.050 |
Why?
|
| Luminescence | 2 | 2016 | 137 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2942 | 0.050 |
Why?
|
| Integrins | 1 | 2006 | 846 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 643 | 0.050 |
Why?
|
| Electrodes | 1 | 2004 | 619 | 0.050 |
Why?
|
| Regeneration | 2 | 2013 | 1485 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2009 | 1357 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1671 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1632 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3752 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 1071 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1620 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2004 | 1686 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 365 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2006 | 711 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2004 | 835 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2006 | 804 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63114 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1774 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 2432 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14557 | 0.050 |
Why?
|
| Photography | 1 | 2003 | 520 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3520 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1060 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 13695 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4204 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 62 | 0.040 |
Why?
|
| Male | 9 | 2019 | 350118 | 0.040 |
Why?
|
| Culicidae | 1 | 2019 | 105 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1095 | 0.040 |
Why?
|
| Algorithms | 3 | 2015 | 13881 | 0.040 |
Why?
|
| Oogenesis | 1 | 2019 | 131 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2645 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 540 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8642 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7722 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Genome | 1 | 2006 | 1808 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 130 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 29 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3616 | 0.040 |
Why?
|
| Karyopherins | 1 | 2018 | 137 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2019 | 210 | 0.040 |
Why?
|
| Robotics | 1 | 2005 | 899 | 0.040 |
Why?
|
| Carcinoma | 1 | 2009 | 2375 | 0.040 |
Why?
|
| Swine | 3 | 2002 | 5917 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6171 | 0.040 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 16 | 0.040 |
Why?
|
| Neurons | 1 | 2016 | 9338 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2018 | 253 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5535 | 0.040 |
Why?
|
| Antigens | 1 | 2002 | 1466 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 2016 | 257 | 0.030 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 537 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15076 | 0.030 |
Why?
|
| Proteomics | 1 | 2009 | 3638 | 0.030 |
Why?
|
| Urea | 1 | 1998 | 450 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2016 | 162 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2016 | 131 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 5021 | 0.030 |
Why?
|
| Culture Media | 1 | 1997 | 908 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 552 | 0.030 |
Why?
|
| Polylysine | 1 | 1994 | 133 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2015 | 149 | 0.030 |
Why?
|
| Polyurethanes | 1 | 1994 | 107 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2009 | 3481 | 0.030 |
Why?
|
| Viscosity | 1 | 1994 | 328 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2016 | 179 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 1994 | 250 | 0.030 |
Why?
|
| Antibodies | 1 | 2002 | 2460 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1994 | 324 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.030 |
Why?
|
| Rabbits | 2 | 2015 | 4894 | 0.030 |
Why?
|
| Steroids | 1 | 2019 | 930 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2252 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 907 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 1152 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 528 | 0.030 |
Why?
|
| Surface-Active Agents | 2 | 2004 | 159 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2014 | 265 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
| Brain | 2 | 2016 | 26385 | 0.030 |
Why?
|
| Dynamins | 1 | 2013 | 152 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 2437 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 1025 | 0.030 |
Why?
|
| Brazil | 1 | 2016 | 1270 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 964 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1856 | 0.030 |
Why?
|
| Capillaries | 1 | 2015 | 773 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 293 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2014 | 2255 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29063 | 0.020 |
Why?
|
| KB Cells | 1 | 2010 | 14 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1654 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 170 | 0.020 |
Why?
|
| Cetrimonium Compounds | 1 | 2010 | 4 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 215 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 23338 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3912 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2018 | 2751 | 0.020 |
Why?
|
| Microcirculation | 1 | 2015 | 1286 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3701 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2012 | 394 | 0.020 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2010 | 71 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2375 | 0.020 |
Why?
|
| India | 1 | 2016 | 2197 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2004 | 5102 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 509 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 2109 | 0.020 |
Why?
|
| Suspensions | 1 | 2009 | 65 | 0.020 |
Why?
|
| Erythrocyte Aggregation | 1 | 2009 | 36 | 0.020 |
Why?
|
| Exosomes | 1 | 2014 | 417 | 0.020 |
Why?
|
| Pancreas | 1 | 2016 | 1686 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 934 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 501 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2009 | 142 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 164 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 913 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2009 | 125 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2013 | 1767 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2009 | 563 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 769 | 0.020 |
Why?
|
| Computer Systems | 1 | 2010 | 483 | 0.020 |
Why?
|
| Models, Structural | 1 | 2008 | 361 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2008 | 107 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 706 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1086 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 1252 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1097 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2009 | 360 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1401 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 713 | 0.020 |
Why?
|
| Cell Shape | 1 | 2008 | 375 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9648 | 0.020 |
Why?
|
| Zebrafish | 1 | 2019 | 2994 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 1454 | 0.020 |
Why?
|
| Microtubules | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Interleukins | 1 | 2011 | 791 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 595 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 964 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11366 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2008 | 351 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2006 | 313 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1889 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20129 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2017 | 2265 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 575 | 0.020 |
Why?
|
| Heating | 1 | 2006 | 97 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2541 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 7913 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1100 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 2121 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 407 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 1584 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2382 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 401 | 0.010 |
Why?
|
| Volatilization | 1 | 2003 | 82 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5853 | 0.010 |
Why?
|
| Biological Transport | 1 | 2008 | 2118 | 0.010 |
Why?
|
| Goats | 1 | 2002 | 171 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9727 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 18111 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 2726 | 0.010 |
Why?
|
| Polyethylene | 1 | 2003 | 184 | 0.010 |
Why?
|
| Microspheres | 1 | 2004 | 777 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 682 | 0.010 |
Why?
|
| Semiconductors | 1 | 2002 | 105 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2967 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4443 | 0.010 |
Why?
|
| Polyesters | 1 | 2003 | 363 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2003 | 321 | 0.010 |
Why?
|
| Biopsy | 1 | 2013 | 6756 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2003 | 454 | 0.010 |
Why?
|
| DNA Repair | 1 | 2010 | 2046 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2002 | 316 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 742 | 0.010 |
Why?
|
| Endothelium | 1 | 2002 | 778 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 676 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Caffeine | 1 | 2003 | 699 | 0.010 |
Why?
|
| United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 13033 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9386 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8301 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 1342 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2635 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2214 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Pressure | 1 | 1999 | 1203 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 163280 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 6103 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 213383 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12261 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17446 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 85781 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29786 | 0.010 |
Why?
|
| Lung | 1 | 2002 | 9856 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 214055 | 0.000 |
Why?
|